Myriad Genetics Posts Revenue Growth, Slightly Widened Loss in Q2 | GenomeWeb

NEW YORK, Feb. 5 - Myriad Genetics on Tuesday said that strong sales of its predictive medicine technologies helped spur an increase in total revenues for its second fiscal quarter.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.